×
News
August 24, 2018

INSIGHT: The Prospects for Pharmaceutical Preemption in the Supreme Court

Bloomberg Law
By Anand Agneshwar Paige Hester Sharpe
Find more content tagged:

Stay up-to-date with the latest topics from the firm.

Email Subscriptions RSS Feed (All Perspectives) RSS Feed (News Only)

People

Anand Agneshwar
Anand Agneshwar
Partner
New York
+1 212.836.8011
anand.agneshwar@arnoldporter.com
VCard
Paige Hester Sharpe
Paige Hester Sharpe
Partner
Washington, DC
+1 202.942.5545
paige.sharpe@arnoldporter.com
VCard

Related Articles

May 16, 2018
West Virginia High Court Reaffirms Traditional Limits on Innovator Liability for Brand Manufacturers
Advisory
October 16, 2017
The Tricky Business of Balancing Public Health Interests with Timely Authorization of Generics
Pink Sheet
July 12, 2017
Brands, Generics, and Biosimilars—Who's Liable for What and Where?
International Association of Defense Counsel Annual Conference, Quebec City, Canada

Email Disclaimer

Reject Accept